Search
+
    SEARCHED FOR:

    EXIDE INDUSTRIES NEWS

    Stock Radar: This battery maker stock turned multibagger in a year; what should investors do?

    Exide Industries has given massive returns to its investors in a year and according to experts there is more steam left in the stock. The stock has an upside of 143% in a year. After consolidating in a narrow range for the past few weeks, it gave a breakout from the same this week. The sudden rise followed by consolidation resembles a breakout above a Flag & Pole pattern.

    Buy Exide Industries, target price Rs 585: Axis Securities

    Exide Industries Ltd. key Products/Revenue Segments include Batteries (Storage), Export Incentives, Other Operating Revenue and Scrap for the year ending 31-Mar-2023.

    F&O stocks: DLF, Exide Industries among 5 stocks with short buildup

    ​In Monday's trading session, the following five stocks witnessed a build of fresh short positions. Let us first understand how this conclusion is reached that whether the stock has seen a buildup of fresh short position or not.

    Battery stocks’ rally may extend after $2 billion surge

    Exide and Amara Raja added a combined market value of about $2 billion in April as investors boosted their bets in the nascent clean car market. Purchase subsidies, lower operating costs and state-level policy will continue to support growth in the industry, analysts said.

    What to do with Tata Communications, Exide Industries, 4 more stocks? Expert Rahul Ghose decodes

    Markets anticipate election impact. May series will be volatile, says Rahul Ghose of Hedged.in. He says a stock-specific approach is advisable now and that he prefers Hindustan Unilever, Elecon and Just Dial and recommends exiting Exide. Nifty's crucial levels are at 21,700-21,800, 22,000. PSU banks are favored while Nifty Pharma index is pivotal at 18,700. IPCA labs strong.

    Add long positions on Monday on dips: Anand James, Geojit Financial Services

    “We will look to add longs on Monday, on dips, which should not exceed 22045, while a direct fall below 21975 will re-activate bearish moves, this time aiming for 21500,” says Anand James, Chief Market Strategist, Geojit Financial Services.

    • It’s a buy-on-dips market but we have not increased cash allocation: Abhay Agarwal

      Abhay Agarwal says "we have recently rebalanced our model portfolio, booked some profits in small and midcaps that we have over allocated to last year at the same time and redeploying them in largecaps where we see more value now. That is the only change that we have made in the portfolio. Other than that, we do not have increased cash allocation."

      Hot Stocks: Brokerage view on Exide Industries, Infosys, Maruti Suzuki and Paytm

      Morgan Stanley maintained an overweight rating on Maruti Suzuki but raised the target price to Rs 14,322 from Rs 11,228 earlier.

      Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 46%

      After a sharp rebound, while nifty is trading in green territory, if one looks at the overall market breadth. There are more declines than advances and that is largely due to market breadth in the mid-cap segment. This is indicative of profit booking happening at the broader market level. At this point of time, one cannot rule out more profit booking which can bring more damage to stock prices in the mid-cap segment. In such times, if one is taking fresh exposure to equity, ensure that there is some level of quality as far as the business and fundamentals are concerned. These selected stocks depict a strong upward trajectory in their overall average score which is based on five key pillars i.e. earnings, fundamentals, relative valuation, risk and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.

      PSU banks look very attractive for the next 3-6 months or even for a year: Pankaj Pandey

      Pankaj Pandey discusses the attractiveness of PSU banks within the BFSI space. He also mentions the potential growth for rating agencies due to government and RBI push for corporate bonds. Tech Mahindra and BirlaSoft are highlighted as companies with strong numbers and attractive prospects. Bajaj Auto's good margins and TVS's success in the EV market are noted. Pankaj Pandey comments on the opportunities in the railway sector, but expresses concerns about valuations.

      Sell Exide Industries, target price Rs 290: Anand Rathi

      Exide Industries Ltd. key Products/Revenue Segments include Batteries (Storage), Export Incentives, Other Operating Revenue and Scrap for the year ending 31-Mar-2023.

      Buy Exide Industries, target price Rs 310: Motilal Oswal

      Exide Industries Ltd., incorporated in the year 1947, is a Mid Cap company (having a market cap of Rs 22822.50 Crore) operating in Auto Ancillaries sector.

      Stocks in news: SJVN, Cipla, Infosys, Zydus, Apollo Tyres

      Cipla's subsidiary InvaGen's manufacturing plant has received five inspectional observations in Form 483 from USFDA.

      Domestic markets get 2018 nostalgia in pre-election year, says Kotak Equities

      While the 50-stock Nifty-50 index has delivered a 67% return in INR terms and 42% in USD terms in the past five years, market returns are expected to remain muted over the next few years, irrespective of the level of economic growth, the brokerage said.

      Corporate actions this week: L&T, Maruti Suzuki to go ex-dividend, Piramal Pharma right issue and more

      Several Indian companies will trade ex-dividend this week, including L&T, Crisil, Coforge, Maruti Suzuki, and Kotak Mahindra Bank. Ex-dividend is when the equity-share price of a company is adjusted for the dividend payout, occurring one or two working days before the record date. The record date lists all shareholders that will qualify for dividends by the record's end.

      Radhakishan Damani buys Health & Glow for ₹750 cr

      According to corporate shareholding data available till June 2023, Damani, Damani publicly holds 14 stocks with a net worth over ₹166,949.6 crore with the largest being VST Industries where he is the single largest shareholder and India Cements, where his 21% ownership makes him the single largest public (non-promoter group) investor. Apart from being an investor in His other retail sector exposure is in Trent, the chain backed by Tata Group.

      Red-hot favourites! MF & PMS managers handpick 10 new smallcaps

      Equitas Small Finance Bank, Birla Corporation, and Sanofi India were the top new small-cap picks by Indian mutual funds and portfolio management scheme (PMS) managers in May. Equitas SFB was selected by 9 mutual funds, 10 PMS, 13 unit-linked insurance plans, and one alternative investment fund. Other small-cap picks included Indiamart Intermesh, Affle India, VIP Industries, Birlasoft, Can Fin Homes, PVR, Inox, and Exide Industries. Meanwhile, managers sold off shares of Zee Entertainment Enterprises, PVR Inox, JB Chemicals, and Gland Pharma.

      Profit Powerhouses: Smallcap stocks with highest EPS growth in FY23. Which ones to buy?

      Smallcap companies are stealing the show and driving growth for portfolios of retail investors, with mid and smallcap indices already at record highs. A study by ETMarkets showed the FY23 EPS of 116 smallcaps surged by over 100%, with at least 11 of these companies reporting growth of more than 1,000%. Telecom firm Vindhya Telelinks topped the list, with its EPS increasing 9,488% to Rs 156.37, while multibagger stock Ramky Infrastructure saw a 4,729% spike to Rs 164.83. Analysts recommend investing in small companies with high growth rates and low starting valuations to maximise returns.

      Nifty faces strong resistance at 18,446: Analysts

      ​Nifty has a strong base around 18,050, which also coincides with the support zone of the short-term moving average. Its sustainability would fuel gradual recovery and help the index to retest 18,500- 18,700. In case of a breakdown, 17,850 would offer cushion.

      Load More
    The Economic Times
    BACK TO TOP
    Advertisement